Syra Health posts Q2 2026 profit of $250K, revenue up 23% YoY to $2.4M

Syra Health Corp

Q2 2026 net income $250,242 vs net loss $(63,596) in Q2 2025; second consecutive profitable quarter.
Revenue grew 23% YoY to $2.4M; gross margin expanded to 44.5%, a company record, up from 38.7%.
EPS $0.02 vs $(0.01) loss; EBITDA turned positive at $253,200 vs $(53,760) in Q2 2025.
Healthcare workforce revenue jumped 87% YoY to $678,113; population health rose 8% to $1.7M.
Anticipates CMS ACCESS Model approval with HealthSync as potential 10-year revenue; cash $2.1M, no long-term debt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.